Anxiety and mood (대한불안의학회지)

Korean Academy of Anxiety Disorders (대한불안의학회)
권호 표지
DOI QR코드

DOI QR Code

A Comparison of the Clinical Characteristics of Panic Disorder with and without Generalized Anxiety Disorder

공황장애 환자에서 범불안장애 공존 유무에 따른 임상적 특징 비교

  • Oh, Jongsoo (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Jung, Sra (Department of Psychiatry, CHA Bundang Medical Center, CHA University) ;
  • Choi, Tai-Kiu (Department of Psychiatry, CHA Bundang Medical Center, CHA University)
  • 오종수 (차의과학대학교 분당차병원 정신건강의학교실) ;
  • 정슬아 (차의과학대학교 분당차병원 정신건강의학교실) ;
  • 최태규 (차의과학대학교 분당차병원 정신건강의학교실)
  • Received : 2016.11.21
  • Accepted : 2017.04.18
  • Published : 2017.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : This study aimed to investigate differences in demographic, clinical characteristics, and quality of life between panic-disorder patients with generalized anxiety disorder (PD+GAD) and without generalized anxiety disorder (PD-GAD). Methods : We examined data from 218 patients diagnosed with PD+GAD (150 patients) and PD-GAD (68patients). The following instruments were applied: Stress coping strategies, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Panic Disorder Severity Scale (PDSS), Anxiety Sensitivity Index-Revised (ASI-R), Albany Panic and Phobia Questionnaire (APPQ), NEO-neuroticism(NEO-N), Short Form health survey-36 (SF-36). Results : Compared to the PD-GAD group, the PD+GAD group had higher scores in emotion-focused coping strategies and clinical severity, such as BDI, BAI, PDSS, ASI, APPQ, and neuroticism. The PD+ GAD group showed lower scores in most scales in SF-36 status than PD-GAD group. Conclusions : This study shows that PD+GAD patients are different from PD-GAD patients in coping strategies, clinical severity and quality of life. It emphasizes the need of personalized therapy in clinical approach among patients with PD+GAD.

Keywords

References

  1. Wittchen HU, Essau CA. Epidemiology of panic disorder: progress and unresolved issues. Journal of Psychiatric Research 1993;27:47-68. https://doi.org/10.1016/0022-3956(93)90017-V
  2. Roy-Byrne PP, Stein MB, Russo J, Mercier E, Thomas R, McQuaid J, et al. Panic disorder in the primary care setting: comorbidity, disability, service utilization, and treatment. The Journal of Clinical Psychiatry 1999;60:492-499. https://doi.org/10.4088/JCP.v60n0713
  3. Brown TA, Antony MM, Barlow DH. Diagnostic comorbidity in panic disorder: Effect on treatment outcome and course of comorbid diagnoses following treatment. Journal of Consulting and Clinical Psychology 1995;63:408. https://doi.org/10.1037/0022-006X.63.3.408
  4. Staecevic V, Uhlenhuth E, Kellner R, Pathak D. Patterns of comorbidity in panic disorder and agoraphobia. Psychiatry Research 1992;42:171-183. https://doi.org/10.1016/0165-1781(92)90080-M
  5. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Archives of General Psychiatry 1994;51:8-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
  6. Fogel BS, Greenberg DB. Psychiatric care of the medical patient: Oxford University Press;2015.
  7. Brown TA, Barlow DH. Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. Journal of Consulting and Clinical Psychology 1992;60:835. https://doi.org/10.1037/0022-006X.60.6.835
  8. Goisman RM, Goldenberg I, Vasile RG, Keller MB. Comorbidity of anxiety disorders in a multicenter anxiety study. Comprehensive Psychiatry 1995;36:303-311. https://doi.org/10.1016/S0010-440X(95)90076-4
  9. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. American Journal of Psychiatry 2001;158:1568-1578. https://doi.org/10.1176/appi.ajp.158.10.1568
  10. Maron E, Lang A, Tasa G, Liivlaid L, Toru I, Must A, et al. Associations between serotonin-related gene polymorphisms and panic disorder. International Journal of Neuropsychopharmacology 2005;8:261-266. https://doi.org/10.1017/S1461145704004985
  11. You J-S, Hu S-Y, Chen B, Zhang H-G. Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatric Genetics 2005;15:7-11. https://doi.org/10.1097/00041444-200503000-00002
  12. Samochowiec J, Hajduk A, Samochowiec A, Horodnicki J, Stepien G, Grzywacz A, et al. Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum. Psychiatry Research 2004;128:21-26. https://doi.org/10.1016/j.psychres.2004.05.012
  13. Scheibe G, Albus M. Predictors and outcome in panic disorder: a 2-year prospective follow-up study. Psychopathology 1997;30:177-184. https://doi.org/10.1159/000285045
  14. Apfeldorf WJ, Spielman LA, Cloitre M, Heckelman L, Shear MK. Morbidity of comorbid psychiatric diagnoses in the clinical presentation of panic disorder. Depression and Anxiety 2000;12:78-84. https://doi.org/10.1002/1520-6394(2000)12:2<78::AID-DA3>3.0.CO;2-5
  15. Gorman JM, Coplan JD. Comorbidity of depression and panic disorder. The Journal of Clinical Psychiatry;1996.
  16. First MB, Gibbon M. The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I) and the Structured Clinical Interview for DSM-IV Axis II Disorders (SCID-II);2004.
  17. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine 2006;166:1092-1097. https://doi.org/10.1001/archinte.166.10.1092
  18. Seo J-G, Park S-P. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. The Journal of Headache and Pain 2015;16:97. https://doi.org/10.1186/s10194-015-0583-8
  19. Lazarus RS, Folkman S. Stress, appraisal, and coping: Springer Publishing Company;1984.
  20. Ceslowitz SB. Burnout and coping strategies among hospital staff nurses. Journal of Advanced Nursing 1989;14:553-557. https://doi.org/10.1111/j.1365-2648.1989.tb01590.x
  21. Beck AT, Steer RA, Brown GK. Beck depression inventory;1996.
  22. Song Y-M, Lee H-K, Kim JW, Lee K. Reliability and validity of the Korean Version of Beck Depression Inventory-II via the internet: Results from a university student sample. Journal of Korean Neuropsychiatric Association 2012;51:402-408. https://doi.org/10.4306/jknpa.2012.51.6.402
  23. Steer RA, Beck AT. Beck Anxiety Inventory;1997.
  24. Shear MK, Brown TA, Barlow DH, Money R, Sholomskas DE, Woods SW, et al. Multicenter collaborative panic disorder severity scale. American Journal of Psychiatry 1997;154:1571-1575. https://doi.org/10.1176/ajp.154.11.1571
  25. Lee EH, Kim JH, Yu BH. Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea. Depression and Anxiety 2009;26:E120-E123. https://doi.org/10.1002/da.20461
  26. Deacon BJ, Abramowitz JS, Woods CM, Tolin DF. The Anxiety Sensitivity Index-Revised: psychometric properties and factor structure in two nonclinical samples. Behaviour Research and Therapy 2003;41:1427-1449. https://doi.org/10.1016/S0005-7967(03)00065-2
  27. Kim JH, Yu BH, Oh KS, Yang JC, Kim Y, Lee SY, et al. A validation study of Korean anxiety sensitivity index-revised (ASI-R). Journal of Korean Neuropsychiatric Association 2004;43:54-61.
  28. Brown TA, White KS, Barlow DH. A psychometric reanalysis of the Albany Panic and Phobia Questionnaire. Behaviour Research and Therapy 2005;43:337-355. https://doi.org/10.1016/j.brat.2004.03.004
  29. Kim JH, Yang JC, Kim JB, Lim KY, Lee SY, Yu BH. A validation study of Korean Albany Panic and Phobia Questionnaire (APPQ). Journal of Korean Neuropsychiatric Association 2004;43:329-336.
  30. Stough C, Donaldson C, Scarlata B, Ciorciari J. Psychophysiological correlates of the NEO PI-R openness, agreeableness and conscientiousness: preliminary results. International Journal of Psychophysiology 2001;41:87-91. https://doi.org/10.1016/S0167-8760(00)00176-8
  31. Nam B, Lee S. Testing the validity of the Korean SF-36 health survey. J Korean Soc Health Stat 2003;28:3-24.
  32. Fawzy FI, Kemeny ME, Fawzy NW, Elashoff R, Morton D, Cousins N, et al. A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Archives of General Psychiatry 1990;47:729-735. https://doi.org/10.1001/archpsyc.1990.01810200037005
  33. Wells A. Meta-cognition and worry: A cognitive model of generalized anxiety disorder. Behavioural and Cognitive Psychotherapy 1995;23:301-320. https://doi.org/10.1017/S1352465800015897
  34. Kim B, Cho SJ, Lee KS, Lee J-Y, Choe AY, Lee JE, et al. Factors associated with treatment outcomes in mindfulness-based cognitive therapy for panic disorder. Yonsei Medical Journal 2013;54:1454-1462. https://doi.org/10.3349/ymj.2013.54.6.1454
  35. Zbozinek TD, Rose RD, Wolitzky-Taylor KB, Sherbourne C, Sullivan G, Stein MB, et al. Diagnostic overlap of generalized anxiety disorder and major depressive disorder in a primary care sample. Depression and Anxiety 2012;29:1065-1071. https://doi.org/10.1002/da.22026
  36. Deacon B, Abramowitz J. Anxiety sensitivity and its dimensions across the anxiety disorders. Journal of Anxiety Disorders 2006;20:837-857. https://doi.org/10.1016/j.janxdis.2006.01.003
  37. Monkul ES, Tural U, Onur E, Fidaner H, Alkin T, Shear MK. Panic Disorder Severity Scale: reliability and validity of the Turkish version. Depression and Anxiety 2004;20:8-16. https://doi.org/10.1002/da.20011
  38. Gunthert KC, Cohen LH, Armeli S. The role of neuroticism in daily stress and coping. Journal of Personality and Social Psychology 1999;77:1087. https://doi.org/10.1037/0022-3514.77.5.1087
  39. Flint J. The genetic basis of neuroticism. Neuroscience & Biobehavioral Reviews 2004;28:307-316. https://doi.org/10.1016/j.neubiorev.2004.01.004
  40. Olff M. Stress, depression and immunity: the role of defense and coping styles. Psychiatry Research 1999;85:7-15. https://doi.org/10.1016/S0165-1781(98)00139-5